Microbial Resistance of Rifaximin in Hepatic Encephalopathy

NCT04736836 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatic Encephalopathy

Interventions

DRUG: Rifaximin

Sponsor

National Hepatology & Tropical Medicine Research Institute